We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+10.96%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
10 Year Est. Return
AUM
$270M
AUM Growth
+$48.6M
Cap. Flow
+$24.3M
Cap. Flow %
9%
Top 10 Hldgs %
28.11%
Holding
581
New
32
Increased
158
Reduced
58
Closed
10

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.92M
2
MSFT icon
Microsoft
MSFT
+$1.71M
3
CMCSA icon
Comcast
CMCSA
+$1.24M
4
MRK icon
Merck
MRK
+$932K
5
TXN icon
Texas Instruments
TXN
+$907K

Sector Composition

Rank Sector Weight
1 Healthcare 17.38%
2 Technology 17.04%
3 Financials 13.65%
4 Industrials 9.38%
5 Communication Services 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$776B
$12.7M 4.72%
26,745
-4
-0% -$1.78K
AAPL icon
2
Apple
AAPL
$4.89T
$9.83M 3.65%
51,073
+10,405
+26% +$1.92M
MSFT icon
3
Microsoft
MSFT
$2.86T
$9.45M 3.51%
25,142
+4,817
+24% +$1.71M
ACN icon
4
Accenture
ACN
$90B
$7.97M 2.96%
22,721
+1,520
+7% +$490K
ICE icon
5
Intercontinental Exchange
ICE
$82.2B
$7.2M 2.67%
56,050
+2,200
+4% +$249K
AMGN icon
6
Amgen
AMGN
$204B
$6.59M 2.44%
22,882
+870
+4% +$237K
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$3.91T
$6.48M 2.41%
46,420
+1,690
+4% +$227K
AMZN icon
8
Amazon
AMZN
$2.5T
$5.68M 2.11%
37,385
+740
+2% +$104K
CNI icon
9
Canadian National Railway
CNI
$78.9B
$5.28M 1.96%
42,018
+5,075
+14% +$575K
NVO
10
Novo Nordisk
NVO
$217B
$4.58M 1.7%
44,290
+7,000
+19% +$692K
BSX icon
11
Boston Scientific
BSX
$66.1B
$4.17M 1.55%
72,117
-100
-0.1% -$5.34K
ABBV icon
12
AbbVie
ABBV
$458B
$3.95M 1.47%
25,517
+4,025
+19% +$587K
SUB icon
13
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$3.93M 1.46%
37,237
TROW icon
14
T. Rowe Price
TROW
$25B
$3.85M 1.43%
35,745
+2,920
+9% +$291K
VEEV icon
15
Veeva Systems
VEEV
$30.3B
$3.82M 1.42%
19,838
+10
+0.1% +$1.88K
GOOG icon
16
Alphabet (Google) Class C
GOOG
$3.91T
$3.77M 1.4%
26,717
+1,640
+7% +$223K
JPM icon
17
JPMorgan Chase
JPM
$936B
$3.59M 1.33%
21,128
-499
-2% -$75.6K
BRK.B icon
18
Berkshire Hathaway Class B
BRK.B
$1.06T
$3.5M 1.3%
9,820
-65
-0.7% -$22.8K
BX icon
19
Blackstone
BX
$103B
$3.47M 1.29%
26,506
+1,750
+7% +$189K
WPC icon
20
W.P. Carey
WPC
$17B
$3.3M 1.23%
50,975
+4,855
+11% +$280K
TMO icon
21
Thermo Fisher Scientific
TMO
$211B
$3.21M 1.19%
6,052
+175
+3% +$84.7K
MRK icon
22
Merck
MRK
$325B
$3.15M 1.17%
28,888
+8,974
+45% +$932K
FISV
23
Fiserv Inc
FISV
$27.4B
$3.07M 1.14%
23,100
-3,465
-13% -$425K
META icon
24
Meta Platforms (Facebook)
META
$1.52T
$2.79M 1.04%
7,885
+525
+7% +$171K
TXN icon
25
Texas Instruments
TXN
$255B
$2.63M 0.97%
15,416
+5,855
+61% +$907K

Similar funds

Brown, Lisle/Cummings's Q4 2023 Portfolio in Review

As of Q4 2023, Brown, Lisle/Cummings held 581 positions worth $270M, up 22% from $221M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $24.3M of net new capital in Q4 2023, opening 32 new positions and adding to 158 existing holdings. Its largest new stake was NEOS S&P 500 High Income ETF: 15,000 shares worth $723K.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Fiserv Inc, an estimated $425K trimmed.

  • Brown, Lisle/Cummings's largest Q4 2023 buy was NEOS S&P 500 High Income ETF: 15,000 shares worth $723K.
  • Brown, Lisle/Cummings added most to Apple in Q4 2023, an estimated $1.92M increase.
  • Brown, Lisle/Cummings's biggest Q4 2023 reduction was Fiserv Inc, cutting an estimated $425K.
  • Brown, Lisle/Cummings fully exited Lumentum in Q4 2023, selling an estimated $132K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $270M portfolio in Q4 2023.
  • Brown, Lisle/Cummings opened 32 new positions and closed 10 in Q4 2023.
  • Brown, Lisle/Cummings's portfolio value rose 22% quarter-over-quarter to $270M.

Based on Brown, Lisle/Cummings's 13F filing for Q4 2023, filed 1 Jul 2024.